Catheter Precision (VTAK) director receives 40,000 stock options at $1.15 strike

Rhea-AI Filing Summary

Catheter Precision, Inc. director Arno Andrew received a grant of stock options as part of his compensation. The award covers 40,000 options to buy common stock at an exercise price of $1.15 per share, expiring on March 26, 2036. The options vest 100% on the 180-day anniversary of the grant date, and following this grant he holds 40,000 derivative securities of this type directly.

Insights

Equity compensation analyst

Director receives 40,000 stock options in routine equity grant.

Director Arno Andrew was granted 40,000 options to buy Catheter Precision common stock at $1.15 per share, expiring on March 26, 2036. The filing classifies this as a grant or award, not an open-market purchase.

The options vest in full 180 days after the grant date, which is a relatively short vesting period compared with multi-year schedules. This grant is direct ownership and appears to be standard board compensation rather than a discretionary market bet.

Because there are no sales and no exercises, and the filing shows only this single award, the economic signal is mainly that the company continues to use equity incentives to align director pay with shareholder outcomes. The scale and impact relative to overall shares outstanding are not detailed in this excerpt.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Arno Andrew

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Options (Right to Buy)	40,000	$0.00	--

Holdings After Transaction: Options (Right to Buy) — 40,000 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 40,000 options Exercise price: $1.15 per share Expiration date: March 26, 2036 +3 more

6 metrics

Options granted 40,000 options Grant to director on March 26, 2026

Exercise price $1.15 per share Strike price for granted options

Expiration date March 26, 2036 Option term end date

Underlying shares 40,000 shares Common stock underlying the options

Post-grant holdings 40,000 derivative securities Total options of this grant held after transaction

Vesting schedule 100% after 180 days Cliff vesting from grant date

Key Terms

Options (Right to Buy), Grant, award, or other acquisition, vesting, exercise price, +1 more

5 terms

Options (Right to Buy) financial

"security_title: "Options (Right to Buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

vesting financial

"Options vest 100% on 180 day anniversary of grant date."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"conversion_or_exercise_price: "1.1500""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arno Andrew

(Last) (First) (Middle)

1670 HIGHWAY 160 WEST

SUITE 205

(Street)

FORT MILL SOUTH CAROLINA 29708

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Catheter Precision, Inc. [ VTAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (Right to Buy)	$1.15	03/26/2026		A		40,000		(1)	03/26/2036	Common Stock	40,000	$0	40,000	D

Explanation of Responses:

1. Options vest 100% on 180 day anniversary of grant date.

	/s/ Andrew Arno	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Catheter Precision (VTAK) director Arno Andrew report on this Form 4?

He reported receiving a grant of 40,000 stock options for Catheter Precision common stock. The options are a derivative award, not an open-market share purchase or sale, and represent standard equity-based director compensation rather than a discretionary trade.

What are the key terms of the 40,000 options granted to Arno Andrew at Catheter Precision (VTAK)?

The award consists of 40,000 options with an exercise price of $1.15 per share, expiring on March 26, 2036. Each option is exercisable into one share of Catheter Precision common stock according to the vesting schedule disclosed in the filing.

When do Arno Andrew’s Catheter Precision (VTAK) options vest?

The filing states that the options vest 100% on the 180-day anniversary of the grant date. This means all 40,000 options become exercisable at once after roughly six months, rather than vesting gradually over multiple years.

Is Arno Andrew buying or selling Catheter Precision (VTAK) shares in this Form 4?

He is not buying or selling shares in the market. The Form 4 records a grant of stock options classified as an acquisition by award. There are no reported open-market purchases, sales, or option exercises in this specific filing.

How many Catheter Precision (VTAK) derivative securities does Arno Andrew hold after this transaction?

After this transaction, he holds 40,000 derivative securities of this option type directly. These represent his full position from this grant, each option being exercisable into one share of common stock once the vesting condition is met.

What does the $1.15 exercise price mean for Arno Andrew’s Catheter Precision (VTAK) options?

The $1.15 exercise price is the fixed amount he must pay per share to convert each option into Catheter Precision common stock. The economic value of the options depends on the future market price relative to this exercise level.